A. Wazana, Physicians and the Pharmaceutical Industry, JAMA, vol.283, issue.3, pp.373-80, 2000.
DOI : 10.1001/jama.283.3.373

J. Lexchin, What information do physicians receive from pharmaceutical representatives?, Can Fam Physician, vol.43, pp.941-946, 1997.

H. Autorité and D. Santé, Manuel pratique : Connaître et comprendre la promotion pharmaceutique et sa régulation[En Ligne]

H. Autorité and D. Santé, Certification de la visite médicale : premier bilan-juillet, En Ligne], 2006.

. Ministère-des-affaires-sociales-et-de-la-santé, [En ligne] Charte de l'information par démarchage ou prospection visant à la promotion des médicaments

D. Zipkin and M. Steinman, Interactions between pharmaceutical representatives and doctors in training, Journal of General Internal Medicine, vol.9, issue.suppl, pp.777-86, 2005.
DOI : 10.1111/j.1553-2712.2002.tb01585.x

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1490177/pdf

P. Norris, A. Herxheimer, J. Lexchin, and P. Mansfield, Drug Promotion: What We Know What We Have Yet to Learn. World Health Organisation and Health Action International

A. Carroll, R. Vreeman, J. Buddenbaum, and T. Inui, To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industrytrainee and industry-physician relationships? Pediatrics, déc, vol.120, issue.6, pp.1528-1535, 2007.
DOI : 10.1542/peds.2007-0363

B. Mintzes, Educational initiatives for medical and pharmacy students about drug promotion. An international cross-sectional survey. World Health Organization and Health Action International, WHO/PSM/PAR, issue.2, 2005.

B. Montague, A. Fortin, and J. Rosenbaum, A systematic review of curricula on relationships between residents and the pharmaceutical industry, Medical Education, vol.264, issue.9, pp.301-309, 2008.
DOI : 10.7326/0003-4819-135-10-200111200-00009

J. Jouquan, L?????valuation des apprentissages des ??tudiants en formation m??dicale initiale, P??dagogie M??dicale, vol.3, issue.1, pp.38-52, 2002.
DOI : 10.1051/pmed:2002006

B. Falissard, Mesurer la subjectivité en santé.2ème édition, pp.103-107, 2008.

P. Bras, P. Ricordeau, B. Rousille, and V. Saintoyant, L'information des médecins généralistes sur lemédicament, pp.247-2007

B. Mintzes, J. Lexchin, J. Sutherland, M. Beaulieu, M. Wilkes et al., Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States, Journal of General Internal Medicine, vol.58, issue.4, pp.1368-75, 2013.
DOI : 10.1176/appi.ps.58.10.1292

. Anon, 15 ans d'observation et un constat: rien à attendre de la visite médicale pour mieux soigner, La Revue Prescrire, vol.26, issue.272, pp.383-389, 2006.

G. Spurling, P. Mansfield, B. Montgomery, J. Lexchin, and J. Doust, Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review, PLoS Medicine, vol.61, issue.10, p.1000352, 2010.
DOI : 10.1371/journal.pmed.1000352.s004

E. Foisset, Étude de l'impact de la visite médicale sur la qualité des prescriptions des médecins généralistes bretons, Thèse de médecine générale, 2012.

H. Autorité and D. Santé, Rapport d'élaboration du référentiel de certification de l'activité d'information par démarchage ou prospection visant à la promotion des médicaments

P. Rédaction, Le Conseil de l'Europe défend la primauté des intérêts de santé publique sur les intérêts industriels, Revue Prescrire, vol.36, issue.391, pp.382-384, 2016.

K. Austad, J. Avorn, and A. Kesselheim, Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review, PLoS Medicine, vol.23, issue.5, pp.1001-1038, 2011.
DOI : 10.1371/journal.pmed.1001037.s002

B. Etain, L. Guittet, N. Weiss, V. Gajdos, and S. Katsahian, Attitudes of Medical Students towards Conflict of Interest: A National Survey in France, PLoS ONE, vol.3, issue.3, pp.92858-104, 2014.
DOI : 10.1371/journal.pone.0092858.t003

F. Montastruc, G. Moulis, A. Palmaro, V. Gardette, G. Durrieu et al., Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator?? Affair, PLoS ONE, vol.42, issue.10, p.104828, 2014.
DOI : 10.1371/journal.pone.0104828.s001

B. Sagarin, R. Cialdini, W. Rice, and S. Serna, Dispelling the illusion of invulnerability: The motivations and mechanisms of resistance to persuasion., Journal of Personality and Social Psychology, vol.83, issue.3, pp.526-567, 2002.
DOI : 10.1037/0022-3514.83.3.526

M. Steinman, M. Shlipak, and S. Mcphee, Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions, The American Journal of Medicine, vol.110, issue.7, pp.551-558, 2001.
DOI : 10.1016/S0002-9343(01)00660-X

P. Scheffer, C. Guy-coichard, D. Outh-gauer, Z. Calet-froissart, M. Boursier et al., Conflict of Interest Policies at French Medical Schools: Starting from the Bottom, PLOS ONE, vol.310, issue.22, p.168258, 2017.
DOI : 10.1371/journal.pone.0168258.s002

A. Shaughnessy, D. Slawson, and J. Bennett, Teaching information mastery:evaluating information provided by pharmaceutical representatives, Fam Med, vol.27, issue.9, pp.581-586, 1995.

S. Agrawal, I. Saluja, and J. Kaczorowski, A Prospective Before-and-After Trial of an Educational Intervention about Pharmaceutical Marketing, Academic Medicine, vol.79, issue.11, pp.1046-50, 2004.
DOI : 10.1097/00001888-200411000-00006

M. Musial, F. Pradère, and A. Tricot, Comment concevoir un enseignement ? Bruxelles : De Boeck, 2012.

J. L. Dejean, évaluation de l'enseignement dans les universités françaises-Rapport n°5 Haut Conseil de l'Evaluation de l'Ecole, 2002.

T. Lotfi, R. Morsi, N. Zmeter, M. Godah, L. Alkhaled et al., Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review, BMC Research Notes, vol.5, issue.78???80, p.720, 2015.
DOI : 10.1001/archfami.5.4.201

W. Mckinney, D. Schiedermayer, N. Lurie, D. Simpson, J. Goodman et al., Attitudes of Internal Medicine Faculty and Residents Toward Professional Interaction With Pharmaceutical Sales Representatives, JAMA: The Journal of the American Medical Association, vol.264, issue.13, pp.1693-1700, 1990.
DOI : 10.1001/jama.1990.03450130065028

M. King, C. Essick, P. Bearman, and J. Ross, Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis, BMJ, vol.346, issue.jan30 5, p.264, 2013.
DOI : 10.1136/bmj.f264

A. Epstein, S. Busch, A. Busch, D. Asch, and C. Barry, Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing? Med Care, pp.199-203, 2013.

R. Watkins and K. J. , What Residents Don???t Know about Physician???Pharmaceutical Industry Interactions, Academic Medicine, vol.79, issue.5, pp.432-439, 2004.
DOI : 10.1097/00001888-200405000-00012

URL : http://pdfs.journals.lww.com/academicmedicine/2004/05000/What_Residents_Don_t_Know_about.12.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1503485622475;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzd++Xw1xrBvVGm3URNugOVtXKdqpAKCMjabX1+f9FU+PuOsCcZWKg9Y+gUDmP3ntBZ;hash|mLNNZFas6BLUyaMxBCdgLA==

S. Suryawati, . Santoso, and . Budiono, Drug advertisements: a critical lesson for Indonesian students, Essential Drugs Monitor, 1997.

B. Mintzes, D. Mangin, and L. Hayes, Understanding and Responding to Pharmaceutical Promotion?A practical guide, World Health Organization/ Health Action International2009. [En ligne]

M. Gedda, Traduction française des lignes directrices CONSORT pour l'écriture et la lecture des essais contrôlés randomisés, Kinesither Rev, vol.15, issue.157, 2015.
DOI : 10.1016/j.kine.2014.11.002

URL : https://doi.org/10.1016/j.kine.2014.11.002

L. Troupe-du-rire, Pourquoi garder son indépendance face aux laboratoires pharmaceutiques?2015.[En Ligne][Consulté le 24 mars2015]Disponible sur : https://latroupedurire.fr, 2016.

N. Orthman, A. Vitry, E. Roughead, S. Ismail, and K. Omar, Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia, BMC Public Health, vol.59, issue.8-9, p.743, 2010.
DOI : 10.1007/s00228-003-0683-2

J. Veloski, S. Tai, A. Evans, and D. Nash, Clinical Vignette-Based Surveys: A Tool for Assessing Physician Practice Variation, American Journal of Medical Quality, vol.74, issue.5, pp.151-158, 2005.
DOI : 10.1097/00001888-199905000-00022

J. Peabody, J. Luck, P. Glassman, S. Jain, J. Hansen et al., Measuring the Quality of Physician Practice by Using Clinical Vignettes: A Prospective Validation Study, Annals of Internal Medicine, vol.141, issue.10, pp.771-80, 2004.
DOI : 10.7326/0003-4819-141-10-200411160-00008

J. Peabody, J. Luck, P. Glassman, T. Dresselhaus, and M. Lee, Comparison of Vignettes, Standardized Patients, and Chart Abstraction, JAMA, vol.283, issue.13, pp.1715-1737, 2000.
DOI : 10.1001/jama.283.13.1715

URL : http://jama.jamanetwork.com/data/journals/jama/4730/joc91362.pdf

H. Autorité and D. Santé, Rapport d'étude. Évaluation des compétences des professionnels de santé et certification des établissements de santé

G. Scallon, L'évaluation des apprentissages dans une approche par compétences, 2004.

P. Shankar, K. Singh, and R. Piryani, Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school, BMC Research Notes, vol.5, issue.1, p.8, 2012.
DOI : 10.1207/S15328015TLM1501_04